Ovid Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.26

+0.04 (+1.80%)

As of Apr 1, 2:31 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 15 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +1,715.9% upside

Low Target $30.97

Average Target $41.04

High Target $66.83

Current Price $2.26

Current
$2.26

Target
$41.04

$30.97 $41.04 avg $66.83

Scenario Analysis

Bear Case

$30.97

1,270.4%

Low target

Base Case

$41.04

+1,715.9%

Avg target

Bull Case

$66.83

+2,857.1%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$45.41

-95.0% from high

52-Week Low

$28.67

+-92.1% from low

Target vs 52W High

$41.04

-9.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%